Grifols S.A. Cash Flow Conversion Efficiency
Grifols S.A. cash flow conversion efficiency. Based on the latest financial reports, Grifols S.A. (GRF) has a cash flow conversion efficiency ratio of 0.020x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€155.27 Million ≈ $181.52 Million USD) by net assets (€7.60 Billion ≈ $8.88 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Grifols S.A. market cap and net worth for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Grifols S.A. (2005–2024)
Cash flow conversion efficiency of Grifols S.A. from 2005 to 2024. This chart illustrates how Grifols S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Grifols S.A. stock quote for real-time trading data and today's change.
Grifols S.A. Cash Flow Conversion Ratio Explained
Grifols S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Grifols S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Grifols S.A. ranked by their cash flow conversion efficiency. Review GRF FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OceanaGold Corporation
TO:OGC
|
0.119x |
|
Gerdau SA ADR
NYSE:GGB
|
0.029x |
|
Blackstone Secured Lending Fund
NYSE:BXSL
|
0.094x |
|
CD PROJEKT (UNSP.ADR)1/4
F:7CD0
|
0.077x |
|
Bachem Holding AG
SW:BANB
|
0.127x |
|
Asseco Poland S.A.
WAR:ACP
|
0.114x |
|
Granite Construction Incorporated
NYSE:GVA
|
0.214x |
|
E Ink Holdings
TWO:8069
|
0.034x |
Annual Cash Flow Conversion Efficiency for Grifols S.A. (2005–2024)
The table below shows the annual cash flow conversion efficiency of Grifols S.A. from 2005 to 2024. Also see Grifols S.A. balance sheet assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €8.61 Billion ≈ $10.06 Billion |
€902.17 Million ≈ $1.05 Billion |
0.105x | +301.21% |
| 2023-12-31 | €7.97 Billion ≈ $9.32 Billion |
€208.28 Million ≈ $243.50 Million |
0.026x | +2133.27% |
| 2022-12-31 | €8.46 Billion ≈ $9.89 Billion |
€-10.87 Million ≈ $-12.70 Million |
-0.001x | -101.75% |
| 2021-12-31 | €8.15 Billion ≈ $9.52 Billion |
€596.98 Million ≈ $697.93 Million |
0.073x | -55.65% |
| 2020-12-31 | €6.72 Billion ≈ $7.86 Billion |
€1.11 Billion ≈ $1.30 Billion |
0.165x | +98.81% |
| 2019-12-31 | €6.85 Billion ≈ $8.00 Billion |
€568.93 Million ≈ $665.14 Million |
0.083x | -47.07% |
| 2018-12-31 | €4.70 Billion ≈ $5.49 Billion |
€737.43 Million ≈ $862.13 Million |
0.157x | -32.21% |
| 2017-12-31 | €3.63 Billion ≈ $4.25 Billion |
€841.75 Million ≈ $984.09 Million |
0.232x | +56.07% |
| 2016-12-31 | €3.73 Billion ≈ $4.36 Billion |
€553.28 Million ≈ $646.84 Million |
0.148x | -34.04% |
| 2015-12-31 | €3.30 Billion ≈ $3.86 Billion |
€742.78 Million ≈ $868.39 Million |
0.225x | -38.80% |
| 2014-12-31 | €2.66 Billion ≈ $3.11 Billion |
€978.93 Million ≈ $1.14 Billion |
0.368x | +30.85% |
| 2013-12-31 | €2.11 Billion ≈ $2.46 Billion |
€592.01 Million ≈ $692.12 Million |
0.281x | +4.19% |
| 2012-12-31 | €1.88 Billion ≈ $2.20 Billion |
€507.12 Million ≈ $592.87 Million |
0.270x | +103.85% |
| 2011-12-31 | €1.66 Billion ≈ $1.95 Billion |
€220.23 Million ≈ $257.47 Million |
0.132x | -10.25% |
| 2010-12-31 | €707.39 Million ≈ $827.01 Million |
€104.25 Million ≈ $121.88 Million |
0.147x | -3.31% |
| 2009-12-31 | €578.53 Million ≈ $676.36 Million |
€88.18 Million ≈ $103.09 Million |
0.152x | -0.07% |
| 2008-12-31 | €481.28 Million ≈ $562.67 Million |
€73.41 Million ≈ $85.82 Million |
0.153x | -33.90% |
| 2007-12-31 | €384.17 Million ≈ $449.13 Million |
€88.64 Million ≈ $103.63 Million |
0.231x | +73.19% |
| 2006-12-31 | €368.35 Million ≈ $430.64 Million |
€49.08 Million ≈ $57.38 Million |
0.133x | -93.77% |
| 2005-12-31 | €55.95 Million ≈ $65.41 Million |
€119.72 Million ≈ $139.97 Million |
2.140x | -- |
About Grifols S.A.
Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, u… Read more